You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for benazepril hydrochloride; hydrochlorothiazide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00170950 ↗ Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension Terminated Novartis Phase 3 2003-10-01 A comparison study of two combination drugs, amlodipine/benazepril and benazepril/HCTZ to evaluate the effectiveness of the combination on reducing heart disease and death in a high risk hypertensive population.
NCT00367094 ↗ Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension Completed Novartis Phase 3 2006-07-01 This study will evaluate efficacy and safety data for benazepril/hydrochlorothiazide in adult Chinese patients with mild to moderate essential hypertension. Patients whose blood pressure is not adequately controlled with benazepril monotherapy during a 4 week run-in period will be randomly allocated to double blind treatment over 8 weeks with either a combination of benazepril/hydrochlorothiazide per day or continuation of benazepril per day.
NCT00649038 ↗ Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg Completed Mylan Pharmaceuticals Phase 1 2002-12-01 The objective of this study was to investigate the bioequivalence of Mylan benazepril HCl and hydrochlorothiazide 20 mg/25 mg to Novartis Lotensin HCT® 20 mg/25 mg combination tablets following a single, oral 40 mg/50 mg (2 x 20 mg/25 mg) dose administration under fed conditions.
NCT00649597 ↗ Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg Completed Mylan Pharmaceuticals Phase 1 2002-11-01 The objective of this study was to investigate the bioequivalence of Mylan benazepril HCl and hydrochlorothiazide 20 mg/25 mg to Novartis Lotensin HCT® 20 mg/25 mg combination tablets following a single, oral 40 mg/50 mg (2 x 20 mg/25 mg) dose administration under fasting conditions.
NCT00778674 ↗ Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed Conditions Completed Ranbaxy Laboratories Limited N/A 2004-10-01 The purpose of this study was to determine the bioavailability of Benazepril and hydrochlorothiazide (HCTZ) from two Benazepril/HCTZ 20 mg/25 mg products after administration of single doses to normal healthy subjects under fed conditions. These data were to be evaluated statistically to determine if the products meet bioequivalence criteria.
NCT00778726 ↗ Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting Conditions Completed Ranbaxy Laboratories Limited N/A 2004-09-01 The purpose of this study was to determine the bioavailability of benazepril and hydrochlorothiazide (HCTZ) from two Benazepril/HCTZ 20 mg/25 mg products after administration of single doses to normal healthy fasted subjects. These data were to be evaluated statistically to determine if the products meet bioequivalence criteria.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for benazepril hydrochloride; hydrochlorothiazide

Condition Name

Condition Name for benazepril hydrochloride; hydrochlorothiazide
Intervention Trials
Healthy 4
Hypertension 4
Albuminuria 1
Diabetes Mellitus, Type 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for benazepril hydrochloride; hydrochlorothiazide
Intervention Trials
Hypertension 4
Diabetes Mellitus, Type 2 1
Diabetes Mellitus 1
Albuminuria 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for benazepril hydrochloride; hydrochlorothiazide

Trials by Country

Trials by Country for benazepril hydrochloride; hydrochlorothiazide
Location Trials
United States 5
China 2
Denmark 1
Sweden 1
Taiwan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for benazepril hydrochloride; hydrochlorothiazide
Location Trials
North Carolina 2
North Dakota 2
New Jersey 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for benazepril hydrochloride; hydrochlorothiazide

Clinical Trial Phase

Clinical Trial Phase for benazepril hydrochloride; hydrochlorothiazide
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
Phase 1 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for benazepril hydrochloride; hydrochlorothiazide
Clinical Trial Phase Trials
Completed 6
Terminated 1
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for benazepril hydrochloride; hydrochlorothiazide

Sponsor Name

Sponsor Name for benazepril hydrochloride; hydrochlorothiazide
Sponsor Trials
Novartis 2
Mylan Pharmaceuticals 2
Ranbaxy Laboratories Limited 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for benazepril hydrochloride; hydrochlorothiazide
Sponsor Trials
Industry 7
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.